entertainment -WSS

entertainment

author：leisure time 2025-09-29 01:39:03 - browse：41

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： UnitedHealth, in a surprise, takes aim at Steward’s physician group

hotspot

explore

WSS

Organ aging and disease risk measured by new blood test

Mayo Clinic plans $5B tech

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

How to pay for weight loss drugs and save Medicare

Hundreds died while taking an arthritis drug, but nobody alerted patients

People with mental disorders often marry others with same

focus

entertainment

entertainment

As demand for Covid shots wanes, Moderna seeks its next success

Trial using CRISPR to edit HIV out of cells disappoints

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Scientific mystery highlights the blind spots in genomics databases

The high cost of giving birth even with insurance

Takeda, Janssen join wearable maker to measure scratching

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Drug companies' payments and gifts affect physicians' prescribing

Jerome Adams on the need for new antivirals for Covid

Pancreatic cancer is often deadly, but new discoveries are raising hope

Wikipedia

J&J to emphasize cancer drugs, stop much of its vaccine research

Takeda, Janssen join wearable maker to measure scratching

Cigna, Humana reportedly in talks to merge

Young boy dies in trial for Pfizer Duchenne gene therapy

Pancreatic cancer is often deadly, but new discoveries are raising hope

Mass General Brigham physicians react to latest merger step

knowledge

hotspot

explore

focus